MiMedx Group, Inc
Symbol: MDXG (NASDAQ)
6.93
▲ (3.29%) 0.221
Company Description:
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Key Stats
- Today's Open: $6.73
- Today's High: $7.215
- Today's Low: $6.705
- Today's Volume: 1.32M
- Yesterday Close: $6.71
- Yesterday High: $6.82
- Yesterday Low: $6.62
- Yesterday Volume: 652.13K
- Last Min Volume: 0
- Last Min High: $6.945
- Last Min Low: $6.931
- Last Min VWAP: $0
Company Profile
- Name: MiMedx Group, Inc
- Website: https://www.mimedx.com
- Listed Date: 2007-08-22
- Location: MARIETTA, GA
- Market Status: Active
- CIK Number: 0001376339
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $992.81M
- Round Lot: 100
- Outstanding Shares: 147.96M
- Asset Type: CS
RECENT FILINGS FOR MDXG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 8-K | View |
| 2025-07-30 | 8-K | View |
| 2025-07-30 | 10-Q | View |
| 2025-07-28 | S-8 | View |
| 2025-07-07 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-20 | 8-K | View |
| 2025-05-23 | ARS | View |
| 2025-05-23 | DEFA14A | View |
| 2025-05-16 | 4 | View |
| 2025-05-13 | 8-K | View |
| 2025-05-05 | 4 | View |
| 2025-04-30 | DEF 14A | View |
Latest News on MDXG